About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01180530

Observational Study of NovoPen Echo® on Safety and Treatment Satisfaction in Children and Adolescents With Type 1 Diabetes

This study is conducted in Asia, Europe and North America. The aim of this observational study is to evaluate the safety of NovoPen Echo® by collecting safety information (incidence of technical compl...

Lead sponsor: Novo Nordisk A/S•5 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Novo Nordisk A/S

Age

2 - 18 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Children/adolescents with type 1 diabetes mellitus
•Use of insulin pen or syringes for at least 12 months

Exclusion Criteria

•Insulin pump or Insuflon® users
•Any disease or condition in children/adolescents which might interfere with the study at the individual physician's discretion

Related studies

Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events

NCT06893341 · Diabetes, Hyperglycemia, and more

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight

Continuous Glucose Monitoring for Women With Gestational Diabetes

NCT06310356 · Gestational Diabetes

RECRUITINGPhase 4

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

NCT06613854 · Type 2 Diabetes Mellitus (T2DM)

A Natural History Study of Metabolic Sizing in Health and Disease

NCT05398783 · Metabolic Disorders, Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 8, 2017Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment358

Start dateOct 2010

Last updatedFeb 8, 2017

Condition

Diabetes Diabetes Mellitus, Type 1 Delivery Systems

Locations shown

Novo Nordisk Investigational Site

Mississauga

Novo Nordisk Investigational Site

Espoo

Novo Nordisk Investigational Site

Kfar Saba

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 8, 2017Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions